The tenth anniversary of RDD® Europe: a great success for the international Respiratory Drug Delivery community

Louveciennes – France, June 5, 2015 – RDD® Europe 2015 hosted 450 pulmonary and nasal drug delivery experts from 31 countries at its latest conference in Antibes, France.

RDD Europe demonstrates once again that it is the “must attend” European event in pulmonary and nasal drug delivery. From May 5 to 8, RDD Europe 2015, recognized internationally by experts for the quality of its programme, attracted delegates from Europe (61%), North America (23%) and the rest of the world’s aerosol community (16%).

RDD Europe is a prestigious event, bringing together scientists, clinicians, business professionals and regulators to further research, development, clinical evaluation and marketing of current and new drugs delivered through the lungs or nose. Its focus is development of innovative products and services to meet patient needs.

APTAR PHARMA’S PRESERVATIVE-FREE MULTI-DOSE SYSTEMS GRANTED IMPORT LICENSE FOR CHINA

Radolfzell, Germany – April 13th, 2015 – Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, has obtained a State Food and Drug Administration (SFDA) import license approval to deliver its preservativefree multi-dose systems to customers in China.

Aptar Pharma recognizes World Pa rkinson’s Day with a new scientific white paper focused on blood-brain barrier drug delivery

Louveciennes, France - April 8, 2015 - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, presents a new scientific white paper, following its recent roundtable held in Paris, France.

The goal of this roundtable was to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood-brain barrier (BBB) and successfully treating a host of central nervous system (CNS) diseases. The CNS, which comprises the brain, spinal cord and a complex system of neurons, integrates and responds to sensory information, playing a key role by coordinating body function. Diseases such Parkinson’s and Alzheimer’s are CNS disorders that affect a growing population.

Aptar Pharma Twister® Chosen for Asthma Therapy

Louveciennes, France - April 2, 2015 - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products has partnered with Shanghai Sine Promod Pharmaceutical Co., Ltd. to develop and launch its new Budesonide DPI (Dry Powder Inhaler), which uses Aptar Pharma’s novel, user-friendly and cost-effective Twister® Dry Powder Inhaler.

The Respiratory Drug Delivery (RDD®) Europe Scientific Conference 2015

Louveciennes, France - December 4, 2014 - The Respiratory Drug Delivery (RDD®) Europe 2015 scientific conference will welcome pulmonary and nasal drug delivery experts from around the world to Antibes, France, May 5-8, 2015. The joint organizers of this prestigious event, RDD Online® and Aptar Pharma, invite you to celebrate RDD Europe’s 10th anniversary and announce the opening of registration at www.rddonline.com/rddeurope2015

Registration opens for the Respiratory Drug Delivery Asia 2014 scientific conference

Louveciennes, France - July 9th, 2014 – the Respiratory Drug Delivery (RDD®) Asia 2014 scientific conference will welcome pulmonary and nasal drug delivery experts from all over the world to Goa, India from November 12-14, 2014. The joint organizers of the first edition of RDD Asia – Aptar Pharma and RDD Online announce the opening of registration.

Aptar Pharma celebrates World Asthma Day with a new scientific publication focused on Inhaler Adherence

Louveciennes, France - May 6th, 2014 - Aptar Pharma, global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, presents a new scientific publication today, following its recent Inhaler Adherence roundtable organized in Paris, France. The theme of this roundtable was “Inhaler Adherence, Exploring Key Factors”.

Aptar Pharma co-organizes the fifth local symposium on Innovative Drug Delivery solutions in Suzhou, China

Louveciennes, France - March 24th, 2014 - Global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, Aptar Pharma, co-organizes the fifth symposium on Innovative Drug Delivery Solutions. This symposium will be held in Suzhou, China, from March 24 to March 26, 2014.

Aptar Pharma co-organizes the fifth local symposium on Innovative Drug Delivery solutions in Suzhou, China

Louveciennes, France - March 24th, 2014 - Global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, Aptar Pharma, co-organizes the fifth symposium on Innovative Drug Delivery Solutions. This symposium will be held in Suzhou, China, from March 24 to March 26, 2014.

APTAR PHARMA PRESENTS THE LATEST RESULTS FROM USER STUDIES CARRIED OUT WITH ITS Pro-Ject® AUTO-INJECTOR

Louveciennes, France - February 10, 2014 - Aptar Pharma Prescription Division, a global solutions provider of innovative and proven aerosol, injection and spray delivery systems for prescription drugs, will present and discuss the latest data from a number of user studies carried out with its Pro-Ject® auto-injector at the Pharmapack Europe conference, to be held in Paris, France on February 12-13, 2014.

Aptar Pharma Co-Organizes the 6th Symposium on Nasal and Pulmonary Drug Delivery In India

Over 180 participants from Europe, Asia and the USA will attend this two-day scientific symposium which will focus specifically on nasal and pulmonary drug delivery. A panel of 14 highly renowned scientists and technical experts will explore and discuss the regulatory challenges facing nasal and pulmonary drug delivery systems. Symposium lectures and facilitated workshops will include:

You Can Control Your Asthma

It is estimated by the World Health Organization (WHO) that approximately 235 million people suffer from asthma in the world. In keeping with the theme of this year's Asthma Day "You can control your Asthma", Aptar Pharma is launching TwisterT, a new versatile affordable capsule-based DPI, with the aim of bringing cost effective drug delivery devices to pharmaceutical companies, helping them market affordable healthcare treatment to patients worldwide.

APTAR PHARMA CELEBRATES ASTHMA DAY WITH A TWISTERT OF INNOVATION

Louveciennes, France - April 30th, 2012 - World leader in the development and manufacturing of nasal and pulmonary drug delivery devices including inhalers for asthma, Aptar Pharma launches TwisterT, a new versatile affordable capsule-based Dry Powder Inhaler (DPI) specifically targeting fast growing markets

Aptar Pharma in tune with the market, patients and prescribers

Before starting development of Prohaler, Aptar Pharma carried out a series of investigations and acceptance studies with healthcare professionals. The aim of these studies was to determine Dry Powder Inhaler (DPI) user expectations and preferences.

APTAR PHARMA\'S CLINICAL STUDY CONFIRMS A MAJOR ADVANCE IN DRY POWDER INHALERS

Louveciennes, France - May 15th, 2012 - World leader in nasal and pulmonary drug delivery devices, Aptar Pharma will unveil the results of the latest patient-focused clinical studies using the Prohaler Dry Powder Inhaler, at the upcoming RDD (Respiratory Drug Delivery) scientifi c conference. RDD 2012 will be held in Phoenix, Arizona, from May 15th - 17th 2012

Aptar pharma landmark dose indicator chosen for Allergic rhinitis

ZETONNAT (ciclesonide) Nasal Aerosol from Sunovion Pharmaceuticals Inc., equipped with an Aptar Pharma Landmark dose indicator, is now available in the USA for the treatment of symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older. Louveciennes, France - August 1, 2012 - World leader in the development and manufacturing of nasal and pulmonary drug delivery devices, Aptar Pharma worked closely with Sunovion Pharmaceuticals for over six years to develop a unique customized Dose Indicator for the delivery of ZETONNA. The innovative actuator offers an alternative to conventional spray pump-based systems.

Jean-Marc Pardonge Appointed As New President of Aptar Pharma Prescription division

Louveciennes, France - November 19th, 2012 - Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma's Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.

Jean-Marc Pardonge succeeds Salim Haffar, and becomes also the new General Manager of Aptar Stelmi (the Stelmi company was recently acquired by Aptargroup).

Register now to attend the rdd europe 2013 scientific conference to be held may 21-24, in berlin, germany.

Louveciennes, France - December 7th, 2012 - The Respiratory Drug Delivery (RDD) Europe 2013 scientific conference will welcome pulmonary and nasal drug delivery experts from all over the world to Berlin, May 21-24, 2013. The joint organizers of this prestigious event, RDD Online and Aptar Pharma, announce the opening of registration at: www.rddonline.com/rddeurope2013

A major scientific meeting for sharing knowledge about nasal and pulmonary drug delivery.

RDD conferences take place in both Europe and the USA in alternate years and are widely regarded as the premier venue for presenting the latest pulmonary and nasal drug delivery advances. After RDD 2012 which was held last May in Phoenix, Arizona, the upcoming RDD Europe 2013 is eagerly awaited. More than 450 delegates are expected to attend the May 21-24 meeting to be held at the Intercontinental Hotel Berlin, Germany. The scientific symposium will welcome an audience of high level academic, industrial and regulatory experts involved in the research, development, investigation, and marketing of existing and new therapies for delivery through the nose or lungs.

Aptar Pharma Landmark Dose Indicator Chosen For New Asthma Combination Therapy

Flutiform, which uses an Aptar Pharma Landmark dose indicator and metering valve, is now available in Germany and the UK. Louveciennes, France - December 5th, 2012 - Aptar Pharma, World leader in the development and manufacturing of nasal and pulmonary drug delivery devices has developed a unique customized Dose Indicator for Flutiform. Flutiform, a SkyePharma product, is licensed to Mundipharma International Corporation Limited in Europe.

Aptar Pharma\'s Twister, A Versatile Dpi For Fast Growing Markets

Louveciennes, France - February 12th, 2013 - Global solution provider of innovative and proven aerosol, injection and spray delivery systems for prescription drugs, Aptar Pharma Prescription Division will present Twister, its latest Dry Powder Inhaler innovation, at the Pharmapack Europe tradeshow to be held in Paris, France, from February 13th to February 14th, 2013.

Louveciennes, France - June 6th, 2013 - Global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, Aptar Pharma expands its worldwide presence through an upgraded multi-language information resources website: www.aptar.com/pharma

A market-focused website
In April 2010, Aptargroup announced the realignment of its activities including its pharmaceutical business under a common brand: Aptar Pharma. The launch of our new website in 2011 associated the Aptar Pharma brand with our established world-leading position as provider of innovative drug delivery devices.

Since this realignment, Aptar Pharma’s website traffic has more than doubled and is continuing to develop. This significant increase shows that users appreciate the easy access to the comprehensive product and service offering content, which is structured by therapeutic application. It is also due to growing demand for information from emerging markets.

Aptar Pharma Unveils A Multi-Language Website To Meet Local Customers’ Needs